Leber’s Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta‐Analysis
BioMed Research International · 2023
DOI: 10.1155/2023/1107866 ↗Kurz gefasst
Metaanalyse in der Zeitschrift BioMed Research International, 2023. Verfasst von Jiajia Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Optic Atrophy, Hereditary, Leber. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
LHON is a progressive disease with early disease onset and male predominance, usually causing devastating visual loss to patients. These systematic review and meta‐analysis are aimed at summarizing epidemiology, disease onset and progression, visual recovery, risk factors, and treatment options of Leber’s hereditary optic neuropathy (LHON) with mitochondrial DNA mutation G11778A from current evidence.
Methods
The PubMed database was examined from its inception date to November 2021. Data from included studies were pooled with either a fixed‐effects model or a random‐effects model, depending on the results of heterogeneity tests. Sensitivity analysis was conducted to test the robustness of results.
Results
A total of 41 articles were included in the systematic review for qualitative analysis, and 34 articles were included for quantitative meta‐analysis. The pooled estimate of proportion of G11778A mutation among the three primary mutations of mitochondrial DNA (G11778A, G3460A, and T14484C) for LHON was 73% (95% CI: 67% and 79%), and the LHON patients with G11778A mutation included the pooled male ratio estimate of 77% (76% and 79%), the pooled age estimate of 35.3 years (33.2 years and 37.3 years), the pooled onset age estimate of 22.1 years (19.7 years and 24.6 years), the pooled visual acuity estimate of 1.4 LogMAR (1.2 LogMAR and 1.6 LogMAR), and the pooled estimate of spontaneous visual recovery rate (in either 1 eye) of 20% (15% and 27%).
Conclusions
The G11778A mutation is a prevalent mitochondrial DNA mutation accounting for over half of LHON cases with three primary mutations. Spontaneous visual recovery is rare, and no effective treatment is currently available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China.
- Real-World Solutions, IQVIA, Shanghai, China.
- Wuhan Neurophth Biotechnology Co., Ltd., Wuhan, China.
- Neurophth Therapeutics, Inc., Boston, USA.
- Tongji Hospital, Tongji Medical College of HUST, Wuhan, China.
ORCID-Profile: Jiajia Yuan, Yangyang Du, Bin Li, Changzheng Chen
Förderung
- Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Yuan, J., Zhao, J., Ye, C., Pang, L., Zhang, X., Luk, A., Du, Y., Fan, K. Y., Zhang, X., Li, B., & Chen, C. (2023). Leber’s Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta‐Analysis. BioMed Research International. https://doi.org/10.1155/2023/1107866
Vancouver
Yuan J, Zhao J, Ye C, Pang L, Zhang X, Luk A, et al. Leber’s Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta‐Analysis. BioMed Research International. 2023. doi:10.1155/2023/1107866
BibTeX
@article{Yuan2023,
author = {Yuan, Jiajia and Zhao, Jiaxun and Ye, Chong and Pang, Long and Zhang, Xin and Luk, Alvin and Du, Yangyang and Fan, Kai Yoon and Zhang, Xiaowen and Li, Bin and Chen, Changzheng},
title = {Leber’s Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta‐Analysis},
journal = {BioMed Research International},
year = {2023},
doi = {10.1155/2023/1107866}
}
EUVIMED